The major factor responsible for growth in the immunotherapy drugs industry is an increase in demand for outsourcing the manufacturing of immunotherapy drugs by several biopharmaceuticals and biotechnological companies and resistance against conventional treatments. The global immunotherapy drugs market was valued at USD 169.47 billion in 2020 and is expected to reach USD 326.36 billion by 2026, growing at a CAGR of 11.54%.
28, 2021 /PRNewswire/ - The 'Immunotherapy Drugs Market - Global Outlook & Forecast 2021-2026' report has been added to 's offering.
